Rubrik, Inc.·4

Apr 8, 7:10 PM ET

Choudary Kiran Kumar 4

4 · Rubrik, Inc. · Filed Apr 8, 2026

Research Summary

AI-generated summary of this filing

Updated

Rubrik (RBRK) CFO Kiran Kumar Sells $1.03M in Shares

What Happened

  • Kiran Kumar, Chief Financial Officer of Rubrik (RBRK), sold 20,000 shares in multiple open-market transactions on April 7, 2026, generating aggregate proceeds of approximately $1,033,733. The sales were executed in four tranches (3,900; 10,000; 5,200; 900 shares) at weighted-average prices shown below.
  • The same Form 4 also reports exercise/conversion entries involving derivative securities recorded at $0 consideration (multiple 5,000-share entries). Those $0 entries reflect option exercises or automatic conversions/settlements recorded without cash paid or received.

Key Details

  • Transaction date: April 7, 2026; Form 4 filed April 8, 2026 (timely).
  • Sales (open market/private sale):
    • 3,900 shares at $50.66 (weighted avg); proceeds $197,574; price range for these trades: $49.90–$50.89. (Footnote F2)
    • 10,000 shares at $51.51 (weighted avg); proceeds $515,100; price range: $50.91–$51.90. (F3)
    • 5,200 shares at $52.55 (weighted avg); proceeds $273,260; price range: $51.97–$52.94. (F4)
    • 900 shares at $53.11 (weighted avg); proceeds $47,799; price range: $53.00–$53.18. (F5)
  • Total sold: 20,000 shares; total proceeds ≈ $1,033,733.
  • Derivative activity: multiple exercise/conversion entries for 5,000-share lots recorded at $0 consideration (see Form 4). (Footnotes F6 and F7 provide vesting/convertibility context in the filing.)
  • Some sales were effected pursuant to a Rule 10b5-1 trading plan adopted October 15, 2025. (F1)
  • Shares owned after the transactions are not listed in the data provided here — see the full Form 4 for post-transaction holdings.
  • Filing timeliness: Filed next day (Apr 8 for Apr 7 trades) — not reported as late.

Context

  • Sales by executives are often routine (diversification, tax/liquidity needs) and do not necessarily signal a change in company outlook; purchases are generally viewed as stronger signals of conviction.
  • The $0 exercise/conversion entries typically indicate option exercises or automatic conversions recorded without cash exchange; in many cases exercised shares are then sold (a common pattern called a cashless exercise or immediate sale), which appears consistent with same-day sales here. For full legal/technical details, consult the Form 4 text and footnotes.

Insider Transaction Report

Form 4
Period: 2026-04-07
Choudary Kiran Kumar
Chief Financial Officer
Transactions
  • Conversion

    Class A Common Stock

    2026-04-07+5,000569,901 total
  • Sale

    Class A Common Stock

    [F1][F2]
    2026-04-07$50.66/sh3,900$197,574566,001 total
  • Sale

    Class A Common Stock

    [F1][F3]
    2026-04-07$51.51/sh10,000$515,100556,001 total
  • Sale

    Class A Common Stock

    [F1][F4]
    2026-04-07$52.55/sh5,200$273,260550,801 total
  • Sale

    Class A Common Stock

    [F1][F5]
    2026-04-07$53.11/sh900$47,799549,901 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F6]
    2026-04-075,00031,450 total
    Exercise: $7.99Exp: 2028-09-17Class B Common Stock (5,000 underlying)
  • Exercise/Conversion

    Class B Common Stock

    [F7]
    2026-04-07+5,0005,000 total
    Class A Common Stock (5,000 underlying)
  • Conversion

    Class B Common Stock

    [F7]
    2026-04-075,0000 total
    Class A Common Stock (5,000 underlying)
Footnotes (7)
  • [F1]This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan, adopted October 15, 2025.
  • [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.90 to $50.89 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote.
  • [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.91 to $51.90 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote.
  • [F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.97 to $52.94 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote.
  • [F5]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.18 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote.
  • [F6]1/4 of the shares subject to the option vested on August 20, 2019, and 1/48 of the shares vested monthly thereafter.
  • [F7]Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock will also be convertible at any time at the option of the Reporting Person into one share of Class A Common Stock.
Signature
/s/ Anne-Kathrin Lalendran, Attorney-in-Fact|2026-04-08

Documents

1 file
  • 4
    form4-04082026_110403.xmlPrimary